KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Gains from Investment Securities (2021 - 2025)

Astrazeneca has reported Gains from Investment Securities over the past 12 years, most recently at -$2.3 billion for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 177.91% year-over-year to -$2.3 billion; the TTM value through Dec 2025 reached -$1.9 billion, down 256.48%, while the annual FY2025 figure was -$13.0 million, 225.0% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$2.3 billion at Astrazeneca, down from $40.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.2 billion in Q3 2024 and troughed at -$2.3 billion in Q4 2025.
  • A 5-year average of -$20.1 million and a median of $13.0 million in 2021 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 214.2% in 2022 and later skyrocketed 36866.67% in 2025.
  • Year by year, Gains from Investment Securities stood at -$259.0 million in 2021, then soared by 413.13% to $811.0 million in 2022, then grew by 1.23% to $821.0 million in 2023, then plummeted by 199.27% to -$815.0 million in 2024, then tumbled by 177.91% to -$2.3 billion in 2025.
  • Business Quant data shows Gains from Investment Securities for AZN at -$2.3 billion in Q4 2025, $40.0 million in Q3 2025, and $1.1 billion in Q2 2025.